TY - JOUR
T1 - Ocular surface microbiota in primary open angle glaucoma
AU - Borroni, Davide
AU - Lo Monaco, Francesco
AU - Ferraro, Silvia
AU - Mazzotta, Cosimo
AU - Settino, Marzia
AU - Gabrielli, Federico
AU - Papa, Filomena Tiziana
AU - Alfonsi, Cinzia
AU - Di Pietro, Fabio
AU - Rizzuto, Vincenzo
AU - Stroffolini, Giacomo
AU - Bonzano, Chiara
AU - Laganovska, Guna
AU - Vanags, Juris
AU - Rechichi, Miguel
AU - Rocha-de-Lossada, Carlos
AU - Ballesteros-Sánchez, Antonio
AU - Zeppieri, Marco
AU - Gagliano, Caterina
N1 - Copyright © 2025 Elsevier Ltd. All rights reserved.
PY - 2025/11/12
Y1 - 2025/11/12
N2 - Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness, yet the contribution of the ocular-surface (OS) microbiota remains poorly defined. We conducted a cross-sectional study including 27 POAG patients on chronic hypotensive therapy and 119 healthy Italian controls, profiled by 16S rRNA amplicon sequencing (Ion GeneStudio S5) and analyzed with QIIME2/phyloseq. POAG samples showed higher α-diversity (Shannon 4.23 vs 2.77; Observed richness 407 vs 154; Wilcoxon q < 1 × 10
-9) and a distinct β-diversity profile (PERMANOVA p = 0.001; R
2 = 0.104). Compositional shifts included depletion of Firmicutes with loss of Staphylococcus in controls' place, and enrichment of Proteobacteria (e.g., Pseudomonas) together with unclassified Enterobacterales and a larger unclassified fraction. Differential-abundance testing identified numerous significant taxa separating groups, consistent with a more diverse yet less defined microbiota in POAG. These findings indicate an ocular-surface dysbiosis associated with POAG in a treatment-exposed cohort, supporting the relevance of host-microbe interactions and motivating longitudinal, treatment-naïve and functional studies before causal or translational inferences.
AB - Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness, yet the contribution of the ocular-surface (OS) microbiota remains poorly defined. We conducted a cross-sectional study including 27 POAG patients on chronic hypotensive therapy and 119 healthy Italian controls, profiled by 16S rRNA amplicon sequencing (Ion GeneStudio S5) and analyzed with QIIME2/phyloseq. POAG samples showed higher α-diversity (Shannon 4.23 vs 2.77; Observed richness 407 vs 154; Wilcoxon q < 1 × 10
-9) and a distinct β-diversity profile (PERMANOVA p = 0.001; R
2 = 0.104). Compositional shifts included depletion of Firmicutes with loss of Staphylococcus in controls' place, and enrichment of Proteobacteria (e.g., Pseudomonas) together with unclassified Enterobacterales and a larger unclassified fraction. Differential-abundance testing identified numerous significant taxa separating groups, consistent with a more diverse yet less defined microbiota in POAG. These findings indicate an ocular-surface dysbiosis associated with POAG in a treatment-exposed cohort, supporting the relevance of host-microbe interactions and motivating longitudinal, treatment-naïve and functional studies before causal or translational inferences.
KW - Glaucoma
KW - Ocular microbiota
KW - 16S rRNA sequencing
KW - Dysbiosis
KW - Metagenomics
UR - https://www.scopus.com/pages/publications/105021502343
U2 - 10.1016/j.exer.2025.110734
DO - 10.1016/j.exer.2025.110734
M3 - Article
C2 - 41237940
SN - 0014-4835
VL - 262
SP - 110734
JO - Experimental Eye Research
JF - Experimental Eye Research
ER -